Elsevier

Neuroscience Research

Volume 45, Issue 3, March 2003, Pages 345-356
Neuroscience Research

Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats

https://doi.org/10.1016/S0168-0102(02)00251-1Get rights and content

Abstract

There is an endocrinological concern that environmental endocrine disrupters (EEDs) may influence sexual differentiation. Bisphenol A (BPA), one of EEDs, is released from polycarbonate plastics, and has been detected in the human umbilical cord. In this study, we examined the effect of BPA on the sexual differentiation of open-field behavior and the sexually dimorphic nuclei in the brain in the offspring of rats exposed to BPA during the fetal and suckling periods at a dosage below the human tolerable daily intake (TDI) level. In the control group, females were more active in the open field and had a larger locus coeruleus (LC) volume than males. BPA abolished and inverted the sex differences of the open-field behavior and the LC volume, respectively, without affecting the reproductive system. We also compared the effects of estrogenic compounds, diethylstilbestrol (DES) and resveratrol (RVT), to that of BPA because of their structural similarities. DES affected the open-field behavior, LC volume and reproductive system, while RVT affected the LC volume and the reproductive system. These results suggest that the brain is highly sensitive to BPA at a dosage below TDI and that the disrupting effects of BPA on sexual differentiation may vary from those of RVT and DES.

Introduction

A great endocrinological concern has recently arisen that certain industrial chemical substances, which are released into our surrounding environment, may influence the central nervous system (CNS) as well as the reproductive system in many animals (Colborn et al., 1993). These chemicals are called ‘environmental endocrine disrupters (EEDs)’. Bisphenol A (BPA) is one of the most famous EEDs and it is released from polycarbonate plastics, epoxy resins of food cans etc. (Krishnan et al., 1993, Society of the Plastics Industry, 1996). Human fetuses have also been reported to be contaminated with BPA (Sakurai and Mori, 2000, Brock et al., 2001). BPA binds to both the estrogen receptor α (ERα) and β (ERβ), and BPA induces a proliferation of estrogen receptor expressing MCF-7 cells in an estrogen-dependent manner (Krishnan et al., 1993, Sohoni and Sumpter, 1998, Hiroi et al., 1999). In addition, BPA has been found to increase both the weight of the uterus and the release of prolactin into the blood in female rodents, similar to estrogen (Steinmetz et al., 1997, Ashby and Tinwell, 1998, Steinmetz et al., 1998). These results indicate that BPA has a common property with estrogenic substances.

The gonadal steroids differentiate neurons and then create the sexual dimorphisms of the brain structure and behavior (MacLusky and Naftolin, 1981, Kelly et al., 1999). Up to now, there is little information about the effect of BPA on the CNS, especially regarding sexual differentiation of the brain and behavior. In a previous study, we found that the BPA exposure during the fetal and suckling periods at a dosage (1.5 mg/kg per day) below the no-observed-adverse-effect level (NOAEL) disrupted the sex difference in open-field behavior and moreover the gender difference of the size of the locus coeruleus (LC), but BPA did not affect the reproductive function or the size of the sexually dimorphic nucleus of the preoptic area (SDN-POA; Kubo et al., 2001). The NOAEL of BPA is determined as 50 mg/kg per day by various in vivo toxicity studies including a reproductive toxicity test. On the basis of the NOAEL, the resolution limitation is calculated as 2.5 mg/l (ppm), and the tolerable daily intake (TDI), which is the maximum acceptable dose in humans, is also calculated as 50 μg/kg per day (from the web site: www: http://www.bisphenol-a.org/health/exposure/consumer/research.html).

For the risk assessment of BPA, it is important to confirm that BPA at or below the TDI does not cause any adverse effects. The main purpose of the present study is to elucidate whether the exposure of very low dose of BPA during the fetal and suckling periods also affects non-reproductive sexual differentiation of both the open-field behavior and the LC structure, and the reproductive function including sexual behavior. Two concentrations of BPA were set at lower levels than that used in our previous study, and the daily intake of BPA was under the TDI in the lower BPA group. An additional purpose of the study is to compare these effects of BPA to those of other estrogenic compounds. In this study, we used two estrogenic chemicals showing structural similarity to BPA. One is trans-resveratrol (RVT) which is a phytoestrogen found in grapes, red wine, peanuts, and other fruits. RVT has an estrogenic potential (Gehm et al., 1997), however, there is little information about the effect of RVT on sexual differentiation of the CNS. The other is diethylstilbestrol (DES) which is a synthetic estrogen, and the estrogenic potential of DES is similar to that of estradiol. DES is often used as an estrogenic control to study the effect of EEDs, because the effects of DES have already been reported regarding sexual differentiation of both the CNS and the reproductive system (MacLusky and Naftolin, 1981, Döhler et al., 1984, Csaba et al., 1986, Tarttelin and Gorski, 1988, Sharpe et al., 1995, Ashby et al., 1997, Vancutsem and Roessler, 1997, Kwon et al., 2000, Atanassova et al., 2000).

Section snippets

Animals and treatments

Female and male Wistar rats at 11 weeks of age were purchased from Kyudo Corp. in Japan and then were housed in standard cages for 2 weeks. After copulation at 13 weeks of age, five dams were exposed to vehicle as control (CON group), six dams to BPA at a dose of 0.1 mg/l (lower BPA-treated group; BPL), six dams to BPA at a dose of 1 mg/l (higher BPA-treated group; BPH), five dams to trans-RVT at a dose of 5 mg/l, and five dams to DES at a dose of 50 μg/l, respectively. All estrogenic compounds

Sexual development

The endopoints regarding the sexual development of the offsprings are shown in Table 1. None of the chemicals induced a change in body weight on PND 1 or AGD in either the male or female offspring. BPA exposure did not affect the sexual development in either the male and female offspring. BPA did not affect the day of testicular descent in the male offspring, or that of vaginal opening in the female offspring. In addition, RVT exposure did not affect male sexual development, while RVT delayed

Discussion

The present study provides the first evidence indicating that the exposure of BPA during the fetal and suckling periods, even at a very low dosage below the TDI, disrupts the normal sexual differentiation in both the brain structure and behavior without any adverse effect on the reproductive system (see Table 4). We noted a disruption of sexual differentiation to be permanently initiated as an organizational effect, because these chemicals were exposed to the offspring only through placental

Acknowledgements

We thank Dr B. Quinn for critical comments and help in preparing this manuscript. We also thank T. Yasaka, Y. Saito and H. Mizuguchi for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (Nos. 13470015 and 13027266 to Shuji Aou, and 11839017 to Minoru Omura) from the Ministry of Education, Science.

References (44)

  • A.K. Slob et al.

    Effects of gonadectomy and exogenous gonadal steroids on sex differences in open field behavior of adult rats

    Behav. Brain Res.

    (1981)
  • M.F. Tarttelin et al.

    Postnatal influence of diethylstilbestrol on the differentiation of the sexually dimorphic nucleus in the rat is as effective as perinatal treatment

    Brain Res.

    (1988)
  • J. Ashby et al.

    Uterotrophic activity of bisphenol A in the immature rat

    Environ. Health Perspect.

    (1998)
  • N. Atanassova et al.

    Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels

    Endocrinology

    (2000)
  • J.L. Bowers et al.

    Resveratrol acts as a mixed agonist/antagonist for estrogen receptor α and β

    Endocrinology

    (2000)
  • J.W. Brock et al.

    Measurement of bisphenol A levels in human urine

    J. Expos. Anal. Environ. Epidemiol.

    (2001)
  • C. Caldji et al.

    Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat

    Proc. Natl. Acad. Sci. USA

    (1998)
  • T. Colborn et al.

    Developmental effects of endocrine-disrupting chemicals in wildlife and humans

    Environ. Health Perspect.

    (1993)
  • G. Csaba et al.

    Influence of neonatal steroid (diethylstilbestrol, allylestrenol) treatment on the sexual behavior of the adult rat

    Med. Biol.

    (1986)
  • K.A. Faber et al.

    Effect of neonatal diethylstilbestrol exposure on volume of the sexually dimorphic nucleus of the preoptic area of the hypothalamus and pituitary responsiveness to gonadotropin-releasing hormone in female rats of known anogenital distance at birth

    Biol. Reprod.

    (1993)
  • B.D. Gehm et al.

    Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

    Proc. Natl. Acad. Sci. USA

    (1997)
  • D. Goldberg et al.

    Method to assay the concentrations of phenolic constituents of biological interest in wines

    Anal. Chem.

    (1996)
  • Cited by (279)

    • Characterizing the obesogenic and fatty liver-inducing effects of Acetyl tributyl citrate (ATBC) plasticizer using both in vivo and in vitro models

      2023, Journal of Hazardous Materials
      Citation Excerpt :

      Many studies have reported the low-dose effects of various chemicals, including lots of well-studied endocrine disruptors, plastic components and plasticizers, pesticides, preservatives, flame retardants, and so on (Melnick et al., 2002; Vandenberg et al., 2012). For example, for the well-studied EDC Bisphenol A (BPA), many studies have reported that effects observed at doses near human exposure levels were not observed at higher doses (Kubo et al., 2003; Mandrup et al., 2016). Meanwhile, growing epidemiological studies also suggest that low internal doses of endocrine disruptors have been linked to obesity (Carwile and Michels, 2011), infertility (Meeker and Stapleton, 2010) and other human diseases.

    • Endocrine-disrupting chemicals and behaviour: A high risk to take?

      2021, Best Practice and Research: Clinical Endocrinology and Metabolism
    View all citing articles on Scopus
    View full text